The migration of macrophages among CCL2-expressing tumor cells decreased after mNOX-E36 (400 μg/mL) treatment compared to that of vehicle treatment [(U87 MG (p = 0.0075) and LN 18 (p = 0.0021)] (Fig. 2A,B). Here, CCL2 is linked to neoplasm.